2 results
13/Nov/2025
DOI: 10.31744/einstein_journal/2025RW1270
ABSTRACT Thalidomide exerts immunomodulatory properties that may be used to treat various conditions. Although its effectiveness in treating Crohn’s disease in pediatric patients has been reported, its safety for off-label use is not well established. This study aimed to analyze the efficacy and safety of thalidomide in children and adolescents with inflammatory bowel disease, specifically Crohn’s and ulcerative colitis. A narrative review of clinical trials and observational studies published between January 2001 and May 2023 that investigated thalidomide use in […]
Keywords: Child; Colitis, ulcerative; Crohn's disease; Efficacy; Inflammatory bowel diseases; Off-label use; Safety; Thalidomide
18/Oct/2019
DOI: 10.31744/einstein_journal/2020AO4745
ABSTRACT Objective To estimate the prevalence of and factors associated with the use of methylphenidate for cognitive enhancement among undergraduate students. Methods Simple random sample of students of the Universidade Federal de Minas Gerais (n=438), invited to answer an online questionnaire about the use of methylphenidate. Data collection occurred from September 2014 to January 2015. The sample was described by means of proportions, means and standard deviations. A multivariate analysis was performed using the Classification and Regression Tree algorithm to […]
Keywords: Central nervous system stimulants; Cognition/drug effects; Methylphenidate; Off-label use; Prevalence; Students